Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

8.08
Delayed Data
As of Jul 25
 -0.02 / -0.25%
Today’s Change
1.72
Today|||52-Week Range
10.87
+114.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.00--0.000.00--
General Expenses33.1K18.9K6.3M4.7M
 
 
 
 
 
Research And Development0.000.002.3M2.6M
 
 
 
Total Operating Expenses33.1K18.9K6.3M4.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-33.1K-18.9K-6.3M-4.7M
 
 
 
 
 
Extraordinary Credit0.000.00--651.1K
 
 
Extraordinary Charge0.000.00-1.4M-249.1K
 
 
 
Interest Expense On Debt0.000.008.0K2.1K
 
 
 
Other Expenses0.000.00-601.0K-23.4K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-33.1K-18.9K-8.3M-4.3M
 
 
 
 
 
Net Income-33.1K-18.9K-8.3M-4.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.0M2.7M7.4M9.5M
 
 
 
 
 
Shares To Calculate EPS Diluted5.0M2.7M7.4M9.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.01$0.00-$1.12-$0.44
 
 
 
 
EPS Diluted-$0.01-$0.01-$1.12-$0.44